Franklin Resources Inc Concert Pharmaceuticals, Inc. Transaction History

Franklin Resources Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.27 - $7.2 $170,799 - $288,000	-40,000 Reduced 57.14%	30,000 $201,000
Q2 2022 Aug 11, 2022	BUY	$2.8 - $6.36 $196,000 - $445,200	70,000 New	70,000 $295,000
Q1 2019 May 14, 2019	SELL	$12.07 - $17.54 $6.72 Million - $9.76 Million	-556,600 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$11.25 - $16.17 $1,822 - $2,619	-162 Reduced 0.03%	556,600 $6.99 Million
Q3 2018 Nov 13, 2018	SELL	$12.82 - $17.88 $259,899 - $362,481	-20,273 Reduced 3.51%	556,762 $8.26 Million
Q2 2018 Aug 14, 2018	BUY	$16.83 - $21.66 $2,272 - $2,924	135 Added 0.02%	577,035 $9.71 Million
Q1 2018 May 10, 2018	SELL	$19.24 - $28.03 $494,467 - $720,371	-25,700 Reduced 4.26%	576,900 $13.2 Million
Q4 2017 Feb 14, 2018	SELL	$13.96 - $29.05 $1.18 Million - $2.45 Million	-84,400 Reduced 12.29%	602,600 $15.6 Million
Q3 2017 Nov 13, 2017	BUY	$13.91 - $15.31 $9.56 Million - $10.5 Million	687,000	687,000 $10.1 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.